相关实验视频
Updated: Jun 19, 2025

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
血小板存储 - - 问题,改进和新视角
Natalia Trochanowska-Pauk1, Tomasz Walski2, Raghvendra Bohara3
1Department of Physics and Biophysics, The Faculty of Biotechnology and Food Science, Wrocław University of Environmental and Life Sciences, 50-375 Wrocław, Poland.
血小板储存损伤限制了输血的可用性. 对存储条件,解决方案,测试和数据建模的研究旨在改善血小板质量并延长关键患者的保质期.
科学领域:
- 输血医学 输血医学
- 生物技术是生物技术.
- 生物物理学的生物物理.
背景情况:
- 血小板输血对于预防重症患者出血至关重要.
- 由于存储损伤和细菌污染风险,血小板的保质期很短 (5 天).
- 血小板储存损伤 (PSLs) 会导致身体和功能退化.
研究的目的:
- 分类和审查与血小板储存病变 (PSLs) 相关的挑战.
- 探索血小板存储的潜在改进和新的视角.
- 提供关于PSL缓解当前研究领域的全面概述.
主要方法:
- 将PSL研究分为四个主要领域:储存条件,添加剂解决方案,先进的血小板测试 (蛋白质组学,代谢组学) 和数据建模 (数学,统计学,人工智能).
- 文献综述和对PSL当前知识的综合.
- 分析不同研究领域的挑战和潜在解决方案.
主要成果:
- PSLs是多方面的,受到储存环境,溶液和固有的血小板性质的影响.
- 蛋白质组和代谢组分析为评估血小板质量提供了新的途径.
- 数据建模,包括人工智能,显示出优化血小板生产和库存管理的前景.
- 添加剂解决方案和优化的储存条件可以减轻某些PSL方面.
结论:
- 解决PSL需要采用多学科方法,结合改进的存储,新型测试和先进的数据分析.
- 进一步研究添加剂解决方案和实时质量监测至关重要.
- 通过科学创新优化血小板的可用性和质量对于患者的护理至关重要.
更多相关视频
10:25Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
Published on: March 19, 2016
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
相关概念视频
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins